Table 3 Aortic valve pathology in the included cohort studies (n = 18)
|  | N | BAV | AS | Pure AS | AR | Pure AR | AS + AR | Prosthetic dysfunction |
|---|---|---|---|---|---|---|---|---|
Sadowski 2015 [12] | 20 | NA | 20 | NA | NA | - | NA | - |
Bartus 2018 [20] | 133 | NA | 108 | 52 | 81 | 25 | 56 | - |
Bartus 2019 [21] | NA | NA | NA | NA | NA | NA | NA | |
Bartus 2021 [22] | NA | 108 | NA | 81 | NA | NA | NA | |
Puskas 2017 [24] | 673 | NA | 604 | 343 | 307 | 46 | 261 | 17 |
Johnston 2021 [25] | ||||||||
Beaver 2023 [26] | ||||||||
El-Sayed Ahmad 2021 [18] | 100 | NA | 93 | NA | 5 | NA | NA | - |
El-Sayed Ahmad 2022 [23] | 152 | NA | 119 | 60 | 92 | 33 | 59 | - |
Bernard 2023 [32] | 217 | NA | 217 | 160 | 57 | - | 57 | - |
Chiariello 2023 [35] | 74 | 30 | 46 | 28 | 46 | 28 | 18 | - |
Francica 2023 [40] | 122 | 59 | NA | NA | 88 | NA | NA | - |
Fukunaga 2022 [29] | 29 | NA | 29 | NA | NA | NA | NA | - |
Maeda 2023 [34] | 64 | 14 | 64 | 16 | 48 | - | 48 | - |
Meuris 2023 [28] | 421 | 308 | 294 | 142 | 92 | 73 | 205 | - |
Porto 2023 [41] | 487 | NA | 487 | 152 | 335 | - | 335 | - |
Shala 2022 [33] | 59 | 10 | 48 | NA | 11 | NA | NA | - |
Useini 2021 [27] | 80 | NA | 69 | NA | 11 | NA | NA | - |